<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01521650</url>
  </required_header>
  <id_info>
    <org_study_id>ProAnest</org_study_id>
    <nct_id>NCT01521650</nct_id>
  </id_info>
  <brief_title>Probiotics Against Pathogenic Bacteria in Connection With Anaesthesia</brief_title>
  <official_title>Probiotics for Reduction of Colonisation With Pathogenic Bacteria in the Oropharynx in Connection With Anaesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Longer surgical procedures require intubation and there is a potential risk of contaminating
      the lower airways with pathogenic bacteria from the mouth and oropharynx.

      Healthy people seldom have pathogenic bacteria originating from the gastro-intestinal canal
      but those do occur among patients, both in those not so sick and patients with more severe
      problems.

      For ICU patients we have seen a reduction of emerging enteric bacteria in patients given oral
      care with probiotics and this is a pilot study to explore the possibility of the same kind of
      positive effects in patients due for longer (more than 4 hours of anesthesia) procedures.

      Randomisation

        -  No prophylaxis

        -  Preparation with a probiotic suspension before intubation.

      Cultures

        -  oropharynx

             -  before treatment

             -  after intubation

             -  before extubation

             -  day 1 postoperatively

        -  tracheal secretions

             -  after intubation

             -  before extubation
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Differences in pathogenic bacteria in the oropharynx and lower airways</measure>
    <time_frame>During hospitalization, up to 4 weeks</time_frame>
    <description>Emerging and resident bacteria will be compared for the cultures taken in the oropharynx and from tracheal secretions in conection with anaestesia and a surgical intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>White blood cells</measure>
    <time_frame>During hospitalization, up to 4 weeks</time_frame>
    <description>WBC taken pre-op and days 1,2,3 post-op</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRP</measure>
    <time_frame>During hospitalization, up to 4 weeks</time_frame>
    <description>CRP taken pre-op and days 1,2,3 post-op</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pneumonia</measure>
    <time_frame>Up till 7 days postoperatively</time_frame>
    <description>X-ray verified infiltrations in combination with expectorates</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>time to discharged from hospital or patients death</time_frame>
    <description>Comparison of length of stay between the intervention group and the control group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">102</enrollment>
  <condition>Oropharyngeal Microbiology</condition>
  <arm_group>
    <arm_group_label>Probiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will gurgle and swallow a mixture of probiotic bacteria</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention. What has been the standard procedure so far</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotics</intervention_name>
    <description>Patients will gurgle and swallow a mixture of probiotic bacteria</description>
    <arm_group_label>Probiotics</arm_group_label>
    <other_name>Lactobacillus plantarum 299</other_name>
    <other_name>Lactobacillus plantarum 299v</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients

          -  Planned interventions

          -  Anaesthesia &gt; 4 hours and requiring intubation

        Exclusion Criteria:

          -  Ulcers in the mouth, oropharynx, oesophagus and stomach

          -  Current infections in the airways

          -  Known immuno deficiences

          -  Emergency cases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bengt klarin, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lund University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lund University Hospital</name>
      <address>
        <city>Lund</city>
        <zip>SE-22185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Stjernquist-Desatnik A, Warfving H, Johansson ML. Persistence of Lactobacillus plantarum DSM 9843 on human tonsillar surface after oral administration in fermented oatmeal gruel. A pilot study. Acta Otolaryngol Suppl. 2000;543:215-9.</citation>
    <PMID>10909023</PMID>
  </reference>
  <reference>
    <citation>Klarin B, Molin G, Jeppsson B, Larsson A. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study. Crit Care. 2008;12(6):R136. doi: 10.1186/cc7109. Epub 2008 Nov 6.</citation>
    <PMID>18990201</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2012</study_first_submitted>
  <study_first_submitted_qc>January 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2012</study_first_posted>
  <last_update_submitted>January 17, 2018</last_update_submitted>
  <last_update_submitted_qc>January 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Region Skane</investigator_affiliation>
    <investigator_full_name>Bengt Klarin</investigator_full_name>
    <investigator_title>MD Consultant</investigator_title>
  </responsible_party>
  <keyword>Probiotics</keyword>
  <keyword>Anaesthesia</keyword>
  <keyword>Intubation</keyword>
  <keyword>Pathogenic bacteria</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Results are intended to be published in a scientific journal</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

